Indian drugmaker Maithili Life Sciences has received a non-compliant report from the Brussels-based Federal Agency for ...

President Donald Trump’s executive order imposing a 10% tariff on Chinese imports is likely to drive up the cost of generic ...

President Donald Trump's steep tariffs on Canada, Mexico and China could worsen ex­ist­ing drug short­ages in the U.S. and raise healthcare costs for patients, some drug trade groups warn. They also ...

C&EN’s tabulation follows approvals from the FDA’s Center for Drug Evaluation and Research; therefore, it does not include blood products, gene therapies, vaccines, and other therapies that ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...

To ensure a higher standard of factuality and reliability, the Sonar API is designed to establish real-time connections to the internet, allowing access to answers grounded in trusted online sources.

which included “multiple microbiological contamination events,” the FDA noted. The French pharma also failed to show that its production process can reproducibly manufacture an API to certain ...

Jan 21 (Reuters) - The U.S. Food and Drug Administration expanded approval for Johnson & Johnson's (JNJ.N), opens new tab nasal spray, Spravato, to allow it to be used as a standalone treatment ...